www.fdanews.com/articles/180436-medtronic-announces-health-canada-approval-for-drug-coated-balloon
![](https://www.fdanews.com/ext/resources/test/Device_Images3/Medtronic.gif?t=1433878552&width=430)
Medtronic Announces Health Canada Approval for Drug-Coated Balloon
February 10, 2017
Medtronic Canada has obtained a license from Health Canada license for its IN.PACT Admiral drug-coated balloon.
The product is a primary endovascular device used in patients with peripheral artery disease in the thigh and behind the knee.
The device is used by inserting a compressed balloon into the artery, inflating the balloon to re-open the blockage and then removing it. The device leaves behind medication designed to help prevent the artery from narrowing. — Cynthia Jessup